Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer
C W Vickery(University of Bristol), Derek Alderson(University of Bristol), Orhan Sezer(Charité - Universitätsmedizin Berlin), Juan Ignacio Arrarás, D Rosemeyer(Klinik Rosenberg), Michael Koller(University Hospital Regensburg), C D Johnson(Southampton General Hospital), Jane Blazeby(Royal College of Surgeons of England), Thierry Conroy(Inserm)
Cited by 201
Related Papers
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
|New England Journal of Medicine|2018|2.8k
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
|Journal of Clinical Oncology|2011|2.1k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k